It's not over when it's over: Long-term symptoms in cancer survivors-a systematic review

International Journal of Psychiatry in Medicine

Volumn 40, Issue 2, 2010, Pages 163-181

  Harrington, Cherise B ^a   Hansen, Jennifer A ^b   Moskowitz, Michal ^c   Todd, Briana L ^c   Feuerstein, Michael ^c,d  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b AMERICAN UNIVERSITY   (United States)

^c Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^d GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

anxiety; cancer survivorship; depression; fatigue; late effects; long term; symptom burden

Indexed keywords

ANTINEOPLASTIC AGENT;

ANXIETY; BODY BURDEN; BREAST CANCER; CANCER PAIN; CANCER SURVIVAL; CANCER SURVIVOR; CANCER THERAPY; COGNITION; COLORECTAL CANCER; CROSS-SECTIONAL STUDY; DEPRESSION; FATIGUE; GYNECOLOGIC CANCER; HUMAN; LONGITUDINAL STUDY; MEDICAL LITERATURE; PAIN; PHYSICAL ACTIVITY; PREVALENCE; PRIMARY TUMOR; PROSTATE CANCER; PSYCHOSOCIAL CARE; PUBLICATION; REVIEW; SEXUAL DYSFUNCTION; SLEEP DISORDER; SYMPTOM; BREAST TUMOR; COGNITIVE DEFECT; COLORECTAL TUMOR; COST OF ILLNESS; FEMALE; FEMALE GENITAL TRACT TUMOR; MALE; NEOPLASM; PROSPECTIVE STUDY; PROSTATE TUMOR; PSYCHOLOGICAL ASPECT; SURVIVOR;

ANXIETY; BREAST NEOPLASMS; COGNITION DISORDERS; COLORECTAL NEOPLASMS; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; DEPRESSION; FATIGUE; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; NEOPLASMS; PAIN; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SLEEP DISORDERS; SURVIVORS;

EID: 77957937471     PISSN: 00912174     EISSN: 15413527     Source Type: Journal    
DOI: 10.2190/PM.40.2.c     Document Type: Review

References (104)

1. Robison L. Cancer survivorship: Unique opportunities for research. Cancer Epidemiology 2004;13:1093.
2. Ness K, Wall M, Oakes M, et al. Physical performance limitations and participation restrictions among cancer survivors: A population-based study. Annals of Epidemiology 2006;16:197-205.
3. Schroevers M, Ranchor A, Sanderman R. The role of age at the onset of cancer in relation to survivors' long-term adjustment: A controlled comparison over an eight-year period. Psychooncology 2004;13:740-752.
4. Mao J, Armstrong K, Bowman M, et al. Symptom burden among cancer survivors: Impact of age and comorbidity. Journal of American Board Family Medicine 2007;20:434-443.
5. Stein KD, Syrjala KL, Andrykowski MA. Physical and psychological long-term and late effects of cancer. Cancer 2008;112:2577-2592.
6. Deimling G, Bowman K, Sterns S, et al. Cancer-related health worries and psychological distress among older adult, long-term cancer survivors. Psychooncology 2006;15:306-320.
7. Ganz P. Late effects of cancer and its treatment. Seminars in Oncology Nursing 2001;17:241-248.
8. Cleeland C, Reyes-Gibby C. When is it justified to treat symptoms? Measuring symptom burden. Oncology 2002;16:64-70.
9. Ries L, Melbert D, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2006. Bethesda, MD: National Cancer Institute; 2009.
10. Fan H, Houede-Tchen N, Yi Q, et al. Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer. Journal of Clinical Oncology 2005;23:8025-8032.
11. Lee TS, Kilbreath SL, Refshauge KM, et al. Quality of life of women treated with radiotherapy for breast cancer. Support Care Cancer 2008;16:399-405.
12. Jacobsen PB, Donovan KA, Small BJ, et al. Fatigue after treatment for early stage breast cancer: A controlled comparison. Cancer 2007;110:1851-1859.
13. Andrykowski MA, Schmidt JE, Salsman JM, et al. Use of a case definition approach to identify cancer-related fatigue in women undergoing adjuvant therapy for breast cancer. Journal of Clinical Oncology 2005;23:6613-6622.
14. Donovan KA, Small BJ, Andrykowski MA, et al. Utility of a cognitive-behavioral model to predict fatigue following breast cancer treatment. Health Psychology 2007; 26:464-472.
15. Berger AM, Higginbotham P. Correlates of fatigue during and following adjuvant breast cancer chemotherapy: A pilot study. Oncological Nursing Forum 2000;27: 1443-1448.
16. Goldstein D, Bennett B, Friedlander M, et al. Fatigue states after cancer treatment occur both in association with, and independent of, mood disorder: A longitudinal study. BMC Cancer 2006;6:240.
17. Alexander S, Minton O, Andrews P, et al. A comparison of the characteristics of disease-free breast cancer survivors with or without cancer-related fatigue syndrome. European Journal of Cancer 2009;45:384-392.
18. Nieboer P, Buijs C, Rodenhuis S, et al. Fatigue and relating factors in high-risk breast cancer patients treated with adjuvant standard or high dose chemotherapy: A longitudinal study. Journal of Clinical Oncology 2005;23:8296-8304.
19. Bower J, Ganz P, Desmond K, et al. Fatigue in long-term breast carcinoma survivors: A longitudinal investigation. Cancer 2006;106:751-758.
20. Curran SL, Beacham AO, Andrykowski MA. Ecological momentary assessment of fatigue following breast cancer treatment. Journal of Behavioral Medicine 2004; 27:425-444.
21. Servaes P, Gielissen MF, Verhagen S, et al. The course of severe fatigue in disease-free breast cancer patients: A longitudinal study. Psychooncology 2007; 16:787-795.
22. de Jong N, Candel MJ, Schouten HC, et al. Course of mental fatigue and motivation in breast cancer patients receiving adjuvant chemotherapy. Annals of Oncology 2005;16:372-382.
23. Conner-Spady BL, Cumming C, Nabholtz JM, et al. A longitudinal prospective study of health-related quality of life in breast cancer patients following high-dose chemotherapy with autologous blood stem cell transplantation. Bone Marrow Transplantation 2005;36:251-259.
24. Mourits MJ, Bockermann I, de Vries EG, et al. Tamoxifen effects on subjective and psychosexual well-being, in a randomised breast cancer study comparing high-dose and standard-dose chemotherapy. British Journal of Cancer 2002;86: 1546-1550.
25. Deshields T, Tibbs T, Fan M, et al. Differences in patterns of depression after treatment for breast cancer. Psychooncology 2006;15:398-406.
26. Burgess C, Cornelius V, Love S, et al. Depression and anxiety in women with early breast cancer: Five year observational cohort study. British Medical Journal 2005;330:702.
27. DiSipio T, Hayes S, Newman B, et al. Health-related quality of life 18 months after breast cancer: Comparison with the general population of Queensland, Australia. Support Care Cancer 2008;16:1141-1150.
28. Costanzo ES, Lutgendorf SK, Mattes ML, et al. Adjusting to life after treatment: Distress and quality of life following treatment for breast cancer. British Journal of Cancer 2007;97:1625-1631.
29. Von Ah D, Kang DH. Correlates of mood disturbance in women with breast cancer: Patterns over time. Journal of Advanced Nursing 2008;61:676-689.
30. Clough-Gorr KM, Ganz PA, Silliman RA. Older breast cancer survivors: Factors associated with change in emotional well-being. Journal of Clinical Oncology 2007;25:1334-1340.
31. Ganz P, Desmond K, Leedham B, et al. Quality of life in long-term, disease-free survivors of breast cancer: A follow-up study. Journal of the National Cancer Institute 2002;94:39-49.
32. Stewart A, Collins B, Mackenzie J, et al. The cognitive effects of adjuvant chemotherapy in early stage breast cancer: A prospective study. Psychooncology 2008; 17:122-130.
33. Bender C, Sereika S, Berga S, et al. Cognitive impairment association with adjuvant therapy in breast cancer. Psychooncology 2006;15:422-430.
34. Wefel J, Lenzi R, Theriault R, et al. Cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: Results of a prospective, randomized, longitudinal trail. Cancer 2004;100:2292-2299. (Pubitemid 38657875)
35. Quesnel C, Savard J, Ivers H. Cognitive impairments associated with breast cancer treatments: Results from a longitudinal study. Breast Cancer Research and Treatment 2009;116:113-123.
36. Schilling V, Jenkins V, Morris R, et al. The effects of adjuvant chemotherapy on cognition in women in breast cancer-preliminary results of an observation longitudinal study. Breast 2005;14:142-150.
37. Collins B, Mackenzie J, Stewart A, et al. Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment. Psychooncology 2009;18:134-143.
38. Schagen S, Muller M, Boogerd W, et al. Change in cognitive function after chemotherapy: A prospective longitudinal study in breast cancer patients. Journal of the National Cancer Institute 2006;98:1742-1745.
39. Jenkins V, Shilling V, Deutsch G, et al. A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. British Journal of Cancer 2006;94:828-834.
40. Hurria A, Rosen C, Hudis C, et al. Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: A pilot prospective longitudinal study. Journal of the American Geriatrics Society 2006;54:925-931. (Pubitemid 43847029)
41. Hermelink K, Henschel V, Untch M, et al. Short-term effects of treatment-induced hormonal changes on cognitive function in breast cancer patients: Results of a multicenter, prospective, longitudinal study. Cancer 2008;113: 2431-2439.
42. Albert U, Koller M, Kopp I, et al. Early self-reported impairments in arm functioning of primary breast cancer patients predict late side effects of auxiliary lymph node dissection: Results from a population-based cohort study. Breast Cancer Research and Treatment 2006;100:285-292.
43. Coster S, Poole K, Fallowfield LJ. The validation of a quality of life scale to assess the impact of arm morbidity in breast cancer patients post-operatively. Breast Cancer Research and Treatment 2001;68:273-282.
44. Engel J, Kerr J, Schlesinger-Raab A, et al. Axilla surgery severely affects quality of life: Results of a 5-year prospective study in breast cancer patients. Breast Cancer Research and Treatment 2003;79:47-57. (Pubitemid 36561042)
45. Karki A, Simonen R, Malkia E, et al. Impairments, activity limitations and participation restrictions 6 and 12 months after breast cancer operation. Journal of Rehabilitation Medicine 2005;37:180-188.
46. Dijkstra PU, Rietman JS, Geertzen JH. Phantom breast sensations and phantom breast pain: A 2-year prospective study and a methodological analysis of literature. European Journal of Pain 2007;11:99-108.
47. Dow K, Lafferty P. Quality of life, survivorship, and psychosocial adjustment of young women with breast cancer after breast-conserving surgery and radiation therapy. Oncology Nursing Forum 2000;27:1555-1564.
48. Buijs C, Rodenhuis S, Seynaeve C, et al. Prospective study of long-term impact of adjuvant high-dose and conventional-dose chemotherapy on health-related quality of life. Journal of Clinical Oncology 2007;25:5403-5409.
49. Ahlberg K, Ekman T, Gaston-Johansson F. Fatigue, psychological distress, coping resources, and functional status during radiotherapy for uterine cancer. Oncology Nursing Forum 2005;32:633-640.
50. Chan YM, Ngan HY, Yip PS, et al. Psychosocial adjustment in gynecologic cancer survivors: A longitudinal study on risk factors for maladjustment. Gynecologic Oncology 2001;80:387-394.
51. Matsushita T, Murata H, Matsushima E, et al. Emotional state and coping style among gynecologic patients undergoing surgery. Psychiatry and Clinical Neurosciences 2007;61:84-93.
52. Goncalves V, Jayson G, Tarrier N. A longitudinal investigation of psychological morbidity in patients with ovarian cancer. British Journal of Cancer 2008;99: 1794-1801.
53. Hipkins J, Whitworth M, Tarrier N, et al. Social support, anxiety and depression after chemotherapy for ovarian cancer: A prospective study. British Journal of Health Psychology 2004;9:569-581.
54. Jensen PT, Groenvold M, Klee MC, et al. Longitudinal study of sexual function and vaginal changes after radiotherapy for cervical cancer. International Journal of Radiation Oncology, Biology, Physics 2003;56:937-949.
55. Jensen PT, Groenvold M, Klee MC, et al. Early-stage cervical carcinoma, radical hysterectomy, and sexual function. A longitudinal study. Cancer 2004;100: 97-106.
56. Pieterse QD, Maas CP, ter Kuile MM, et al. An observational longitudinal study to evaluate miction, defecation, and sexual function after radical hysterectomy with pelvic lymphadenectomy for early-stage cervical cancer. International Journal of Gynecological Cancer 2006;16:1119-1129.
57. Chan Y, Nagan H, Li B, et al. A longitudinal study on quality in life after gynecologic cancer treatment. Gynecologic Oncology 2001;83:10-19.
58. Hodgkinson K, Butow P, Fuchs A, et al. Long-term survival from gynecologic cancer: Psychosocial outcomes, supportive care needs, and positive outcomes. Gynecologic Oncology 2007;104:381-389.
59. Simonelli LE, Fowler J, Maxwell GL, et al. Physical sequelae and depressive symptoms in gynecologic cancer survivors: Meaning of life as a mediator. Annals of Behavioral Medicine 2008;35:275-284.
60. Bodurka-Bevers D, Basen-Engquist K, Carmack CL, et al. Depression, anxiety, and quality of life in patients with epithelial ovarian cancer. Gynecologic Oncology 2000;78:302-308.
61. Distefano M, Riccardi S, Capelli G, et al. Quality of life and psychological distress in locally advanced cervical cancer patients administered pre-operative chemoradio-therapy. Gynecologic Oncology 2008;111:144-150.
62. Liavaag AH, Dorum A, Fossa SD, et al. Controlled study of fatigue, quality of life, and somatic and mental morbidity in epithelial ovarian cancer survivors: How lucky are the lucky ones? Journal of Clinical Oncology 2007;25:2049-2056.
63. Carter J, Rowland K, Chi D, et al. Gynecologic cancer treatment and the impact of cancer-related infertility. Gynecologic Oncology 2005;97:90-95.
64. Champion V, Williams S, Miller A, et al. Quality of life in long-term survivors of ovarian germ cell tumors: A gynecologic oncology group study. Gynecologic Oncology 2007;105:687-694.
65. Fox SW, Lyon D. Symptom clusters and quality of life in survivors of ovarian cancer. Cancer Nursing 2007;30:354-361.
66. Wenzel L, Ekman T, Gaston-Johansson F, et al. Quality of life in long-term survival cervical survivors. Gynecologic Oncology 2005;97:310-317.
67. Vistad I, Fossa SD, Kristensen GB, et al. Chronic fatigue and its correlates in long-term survivors of cervical cancer treated with radiotherapy. British Journal of Obstetrics and Gynecology 2007;114:1150-1158.
68. Holzner B, Kemmler G, Meraner V, et al. Fatigue in ovarian carcinoma patients: A neglected issue? Cancer 2003;97:1564-1572.
69. Matulonis UA, Kornblith A, Lee H, et al. Long-term adjustment of early-stage ovarian cancer survivors. International Journal of Gynecological Cancer 2008;18: 1183-1193.
70. Stewart DE, Wong F, Duff S, et al. "What doesn't kill you makes you stronger": An ovarian cancer survivor survey. Gynecologic Oncology 2001;83:537-542.
71. Park SY, Bae DS, Nam JH, et al. Quality of life and sexual problems in disease-free survivors of cervical cancer compared with the general population. Cancer 2007;110:2716-2725.
72. Tangjitgamol S, Manusirivithaya S, Hanprasertpong J, et al. Sexual dysfunction in Thai women with early-stage cervical cancer after radical hysterectomy. International Journal of Gynecological Cancer 2007;17:1104-1112.
73. Lindau ST, Gavrilova N, Anderson D. Sexual morbidity in very long term survivors of vaginal and cervical cancer: A comparison to national norms. Gynecologic Oncology 2007;106:413-418.
74. Miller D, Sanda M, Dunn R, et al. Long-term outcomes among localized prostate cancer survivors: Health-related quality of life changes after radical prostatectomy, external radiation, and brachytherapy. Journal of Clinical Oncology 2005;23: 2772-2780.
75. Green H, Pakenham K, Headley B, et al. Alterned cognitive function in men treated for prostate cancer with luteinizing hormone-releasing hormone analogues and cyproterone acetate: A randomized controlled trial. BJU International 2002; 90:427-432.
76. Jenkins V, Bloomfield D, Shilling V, et al. Does neoadjuvant hormone therapy for early prostate cancer affect cognition? Results from a pilot study. BJU International 2005;96:48-53. (Pubitemid 40942867)
77. Stone P, Hardy J, Huddart R, et al. Fatigue in patients with prostate cancer receiving hormone therapy. European Journal of Cancer 2000;36:1134-1141.
78. Penson D, McLerran D, Feng Z, et al. 5-Year urinary and sexual outcomes after radical prostatectomy: Results from the prostate cancer outcomes study. Journal of Urology 2005;173:1701-1705.
79. Maliski S, Kwan L, Elashoff D, et al. Symptom clusters related to treatment for prostate cancer. Oncology Nursing Forum 2008;35:786-793.
80. Hamilton A, Stanford J, Gilliland F, et al. Health outcomes after external-beam radiation therapy for clinically localized prostate cancer: Results from the prostate outcomes study. Journal of Clinical Oncology 2001;19:2517-2526. (Pubitemid 32391223)
81. Potosky A, Davis W, Hoffman R, et al. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: The prostate cancer outcomes study. Journal of National Cancer Institute 2004;96.
82. Stanford J, Feng Z, Hamilton A, et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: The Prostate cancer outcomes study. Journal of the American Medical Association 2000;283:354-360.
83. Fransson P. Patient-reported lower urinary tract symptoms, urinary incontinence, and quality of life after external beam radiotherapy for localized prostate cancer\15 years' follow-up. A comparison with age-matched controls. Acta Oncologica 2008;47:852-861.
84. Monahan P, Champion V, Rawl S, et al. What contributes more strongly to predicting QOL during 1-year recovery from treatment for clinically localized prostate cancer: 4 weeks-post-treatment depressive symptoms or type of treatment? Quality of Life Research 2007;16:399-411.
85. Deimling G, Sterns S, Bowman K, et al. The health of older-adult, long-term cancer survivors. Cancer Nursing 2005;28:415-424.
86. Hervouet S, Savard J, Simard S, et al. Psychological functioning associated with prostate cancer: Cross-sectional comparison of patients treated with radiotherapy, brachytherapy, or surgery. Journal of Pain & Symptom Management 2005;30: 474-484.
87. Ukoli F, Lynch B, Adams-Campbell L. Radical prostatectomy and quality of life among African Americans. Ethnicity & Disease 2006;16:988-993.
88. Savard J, Simard S, Hervouet S, et al. Insomnia in men treated with radical prostatectomy for prostate cancer. Psychooncology 2005;14:147-156.
89. Schmidt C, Bestmann B, Kuchler T, et al. Impact of age on quality of life in patients with rectal cancer. World Journal of Surgery 2005;29:190-197.
90. Schmidt C, Bestmann B, Kuchler T, et al. Gender differences in quality of life of patients with rectal cancer. A five-year prospective study. World Journal of Surgery 2005;29:1630-1641.
91. Camilleri-Brennan J, Steele R. Prospective analysis of quality of life and survival following mesorectal excision for rectal cancer. British Journal of Surgery 2001; 88:1617-1622.
92. Kerr J, Engel J, Schlesinger-Raab A, et al. Doctor-patient communication: Results of a four-year prospective study in rectal cancer patients. Diseases of the Colon & Rectum 2003;46:1038-1046. (Pubitemid 36992985)
93. Ramsey S, Berry K, Moinpour C, et al. Quality of life in long term survivors of colorectal cancer. American Journal of Gastroenterology 2002;97:1228-1234.
94. Di Fabio F, Koller M, Nascimbeni R, et al. Long-term outcome after colorectal cancer resection. Patients' self-reported quality of life, sexual dysfunction and surgeons' awareness of patients' needs. Tumori 2008;94:30-35.
95. Gatta G, Ciccolallo L, Faivre J, et al. Late outcomes of colorectal cancer treatment: A FECS-EUROCARE study. Journal of Cancer Survivorship 2007: 247-254.
96. Feuerstein M (ed.). Handbook of cancer survivorship. New York: Springer; 2006.
97. Ganz P, Horning SJ (eds.). Cancer survivorship: Today and tomorrow. New York: Springer; 2007.
98. Rowland J, Manotto A, Aziz N, et al. Cancer survivorship\United States 1971-2001. MMWR 2004;53:526-529.
99. Adler NE, Page AEK (eds.). Cancer care for the whole patient: Meeting psychosocial health needs. Washington: National Academies Press; 2007.
100. Cleeland C, Bennett G, Dantzer R, et al. Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer 2003;97:2919-2925.
101. Morrow G, Shelke A, Roscoe J, et al. Management of cancer-related fatigue. Cancer Investigations 2005;23:229-239.
102. Willingham M, Nail L, Burke M, et al. Fatigue and the cancer experience: The state of the knowledge. Oncology Nursing Forum 1994;21:23-26.
103. Barsevick A, Dudley W, Beck S. Cancer-related fatigue, depressive symptoms, and functional status. Nursing Research 2006;55:366-372.
104. Tavio M, Milan I, Tirelli U. Cancer-related fatigue (Review). International Journal of Oncology 2002;21:1093-1099.